142 related articles for article (PubMed ID: 7742592)
1. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
Pélissier E; Bosset JF; Meneveau N
Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.
Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258
[TBL] [Abstract][Full Text] [Related]
3. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
5. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
Stapel A; Franke U; Putzki H
Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
[TBL] [Abstract][Full Text] [Related]
6. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
Körner H; Söreide K; Stokkeland PJ; Söreide JA
Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
9. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of serum protein-bound hexose--an aid in the diagnosis and after-care of colorectal cancers?].
Putzki H; Reichert B; Hue M
Zentralbl Chir; 1992; 117(6):331-3. PubMed ID: 1519392
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
15. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers in patients with relapse of colorectal carcinoma.
Lipská L; Visokai V; Levý M; Svobodová S; Kormunda S; Fínek J
Anticancer Res; 2007; 27(4A):1901-5. PubMed ID: 17649792
[TBL] [Abstract][Full Text] [Related]
17. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
18. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
Nakayama T; Watanabe M; Teramoto T; Kitajima M
Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer.
Park IJ; Choi GS; Jun SH
Anticancer Res; 2009 Oct; 29(10):4303-8. PubMed ID: 19846991
[TBL] [Abstract][Full Text] [Related]
20. A study of the effects of bowel preparation on CEA levels in patients undergoing surveillance colonoscopy.
So JB; Alexander DJ; Chia YW; Ngoi SS; Lee L; Goh PM
J R Coll Surg Edinb; 1997 Apr; 42(2):105-6. PubMed ID: 9114681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]